Anti-vascular therapies in ovarian cancer: moving beyond anti-VEGF approaches.

Choi HJ, Armaiz Pena GN, Pradeep S, Cho MS, Coleman RL, Sood AK. Anti-vascular therapies in ovarian cancer: moving beyond anti-VEGF approaches. Cancer Metastasis Rev. 2015 Mar; 34(1):19-40.

View in: PubMed

subject areas

Angiogenesis Inhibitors
Antineoplastic Agents
Female
Humans
Neovascularization, Pathologic
Ovarian Neoplasms
Protein Kinase Inhibitors
Signal Transduction
Treatment Outcome
Vascular Endothelial Growth Factor A

authors with profiles

Guillermo N Armaiz Pena

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support